Text · Opinion parliamentary committee draft
On gender inequalities in health, specifically as regards gender-specific conditions
Document SANT-PA-784154 · 2025/2074(INI)
- Kind
- Opinion parliamentary committee draft SANT-PA-784154
- Date
- 11 February 2026
- Committee
- Committee on Public Health
- Rapporteur
- Catarina Martins
- Dossier
- 2025/2074(INI)
More facts (3)
- Formats
- Official page PDF Word
- Subject matter
- DISC, SANI
- Reference
- 2025/2074(INI)
Text
The text as parsed from the official Word file. Every paragraph has a link (¶) and can be saved to a project as a passage.
The text consists only of the parts below (back matter, procedure pages).
Back matter, 2
Parts that accompany the text rather than belong to it: explanatory statement, annexes, opinions appended by other committees. Collapsed.
Amendments 151 blocks
The Committee on Public Health submits the following to the Committee on Women's Rights and Gender Equality, as the committee responsible:
| Motion for a resolution | Amendment |
|---|---|
| -A. whereas women make up half of the global population, yet healthcare systems, including medical training, diagnoses and treatment, are not designed around their experiences across different stages of life; |
| Motion for a resolution | Amendment |
|---|---|
| Ba. whereas generic medicinal products are authorised on the basis of bioequivalence studies, which are still often conducted predominantly on male participants and are not systematically analysed for sex differences; whereas reference medicinal products were historically tested mainly in men; whereas differences in formulation between generic and reference medicinal products may affect bioavailability, raising uncertainties as to whether bioequivalence demonstrated in men can be equally assumed for women; |
| Motion for a resolution | Amendment |
|---|---|
| Ca. whereas women’s health data is often not collected, not published in the public domain, or incomplete; whereas improving the accuracy of data collection and setting standards for sex- and gender-based data collection could help to clarify the true burden of disease, particularly for women-specific conditions; |
| Motion for a resolution | Amendment |
|---|---|
| Cb. whereas AI in healthcare risks exacerbating gender inequality by replicating historical biases, with algorithms often trained in male-dominated data leading to underdiagnosis or misdiagnosis for women; whereas these biases, stemming from non-representative datasets, can cause AI tools to downplay female medical symptoms, such as those related to cardiovascular disease or pain management; |
| Motion for a resolution | Amendment |
|---|---|
| Cc. whereas the collection of sex-disaggregated data should become mandatory in order to make AI an effective support for safe healthcare, and one that reflects biological differences and tracks women’s health across the different stages of life; |
| Motion for a resolution | Amendment |
|---|---|
| Ja. whereas women are diagnosed with cancer on average two and a half years later than men; |
| Motion for a resolution | Amendment |
|---|---|
| Jb. whereas metabolic diseases such as diabetes are diagnosed about four and a half years later in women than in men; |
| Motion for a resolution | Amendment |
|---|---|
| La. whereas in the EU, cardiovascular diseases account for 40 % of all female deaths, more than all cancers combined; whereas women are 20 % more likely than men to die following a heart attack due to a misdiagnosis of symptoms; whereas women wait more than five times longer than men to receive a heart failure diagnosis and are twice as likely to be misdiagnosed; |
| Motion for a resolution | Amendment |
|---|---|
| Ma. whereas refugee and ethnic minority women, women living in poverty and experiencing homelessness, older women, women with disabilities, women residing in rural and socio-economically disadvantaged areas and individuals from LGBTI+ communities encounter multiple and intersecting barriers to accessing healthcare services; |
| Motion for a resolution | Amendment |
|---|---|
| Na. whereas diseases that only or predominantly affect women continue to be severely underfunded and under researched; |
| Motion for a resolution | Amendment |
|---|---|
| Nb. whereas a better understanding of hormones and the biology of sex-related differences may improve women’s health across different stages of life; |
| Motion for a resolution | Amendment |
|---|---|
| Nc. whereas clinical practice guidelines often do not reflect best-practice clinical care for women, including the understanding of sex-based differences in the presentation and treatment of conditions; |
| Motion for a resolution | Amendment |
|---|---|
| Nd. whereas, to provide the best care, healthcare professionals should be equipped with accurate and updated knowledge of biological differences, including sex-specific manifestations of symptoms, which will be reflected in the implementation of differentiated diagnosis and targeted treatments; |
| Motion for a resolution | Amendment |
|---|---|
| 4a. Calls for the incorporation of a sex and gender informed perspective in all EU legislation and initiatives, such as the Cardiovascular Health Plan, the European Biotech Act, the assessment of the implementation of the Beating Cancer Plan and others; |
| Motion for a resolution | Amendment |
|---|---|
| 6a. Urges the EMA to ensure that the evaluation and authorisation of generic medicinal products adequately take into account sex-specific differences in testing and analysis, with a view to ensuring equal safety and efficacy for all patients; |
| Motion for a resolution | Amendment |
|---|---|
| 14a. Calls for the integration of menopause-related care into national health systems, providing women with the right information and support, including access to psychosocial support, and empowering women to recognise symptoms earlier and to seek appropriate care; |
| Motion for a resolution | Amendment |
|---|---|
| Cardiovascular diseases |
| Motion for a resolution | Amendment |
|---|---|
| 15a. Calls for the development of personalised diagnosis and treatment strategies tailored to women, in particular those that have faced pregnancy risks, such as pre-eclampsia and gestational diabetes, and those undergoing perimenopause and menopause, when hormonal changes can increase cardiovascular risk; |
| Motion for a resolution | Amendment |
|---|---|
| 15b. Calls for the design and implementation of a cardiovascular risk calculator, tailored to female physiology and factors at different stages of life, aiming to facilitate prevention, earlier detection, support and medical training; |
| Motion for a resolution | Amendment |
|---|---|
| 15c. Calls for different clinical specialities to create multidisciplinary care cooperation strategies in order to break silos and exchange data and information on the different stages of women’s lives, including pregnancy, menopause and comorbidities; |
| Motion for a resolution | Amendment |
|---|---|
| 18a. Calls for the inclusion of women’s health as a priority and for it to be mainstreamed in the new EU research programmes, such as the next EU framework programme for research and innovation (FP10), the forthcoming European innovation act, and the ECF, thus ensuring gender-sensitive design in all research proposals; |
| Motion for a resolution | Amendment |
|---|---|
| 18b. Calls for the creation of a multidisciplinary expert group to identify research gaps, support collaboration and provide evidence-based advice for improving women’s health across the EU and globally; |
| Motion for a resolution | Amendment |
|---|---|
| 18c. Calls for the development and implementation of a Women’s health research agenda, with a specific earmarked budget from the new FP10, to support research into women’s specific conditions that often lack sufficient investment and are under-studied, such as endometriosis, menopause transition, urological and urogynaecological disorders, maternal health, pre- and post-partum complications, mental health, certain cancers, and cardiovascular and metabolic diseases, among others; |
| Motion for a resolution | Amendment |
|---|---|
| AI tools and medical devices |
| Motion for a resolution | Amendment |
|---|---|
| 18d. Calls for the collection of sex-disaggregated data and inclusive data to be binding in all AI tools and machine learning systems; |
| Motion for a resolution | Amendment |
|---|---|
| 18e. Calls for the EU to ensure that all medical devices are designed, tested and validated for diverse anatomical characteristics across all populations and ages; |
| Motion for a resolution | Amendment |
|---|---|
| Education and training |
| Motion for a resolution | Amendment |
|---|---|
| 18f. Calls for the EU and its Member States to integrate women’s health comprehensively into medical and nursing education, ensuring all healthcare professionals receive training on women-specific conditions, including menstrual disorders, endometriosis, polycystic ovarian syndrome, menopause and urological and urogynaecological disorders, as well as training on hormone replacement therapy (HRT); |
| Motion for a resolution | Amendment |
|---|---|
| 18g. Supports the redesign of medical curricula to reflect sex- and gender-based differences, including the needs and experiences of transgender, gender-diverse and vulnerable populations; |
| Motion for a resolution | Amendment |
|---|---|
| 18h. Calls for the inclusion of gynaecological endocrinology in medical training, where current coverage remains patchy or absent; |
Annex: declaration of input 4 blocks
Pursuant to Article 8 of Annex I to the Rules of Procedure, the rapporteur for opinion declares that she included in her draft opinion input on matters pertaining to the subject of the file that she received, in the preparation of the draft opinion, from the following interest representatives falling within the scope of the Interinstitutional Agreement on a mandatory transparency register, or from the following representatives of public authorities of third countries, including their diplomatic missions and embassies:
| 1. Interest representatives falling within the scope of the Interinstitutional Agreement on a mandatory transparency register |
| Netherlands Women's Health Research & Innovation Center |
| Deutsche Stiftung Weltbevölkerung (DSW) |
| 2. Representatives of public authorities of third countries, including their diplomatic missions and embassies |
Where natural persons are identified in the list by their name, by their function or by both, the rapporteur for opinion declares that she has submitted to the natural persons concerned the European Parliament's Data Protection Notice No 484 (https://www.europarl.europa.eu/data-protect/index.do), which sets out the conditions applicable to the processing of their personal data and the rights linked to that processing.
Connections
The dossier, the decisions on this text and its other versions.
No connections found for this item.
Sources & citation
Where the facts on this page come from, and how to cite it.
- Data source
- Licensed CC BY 4.0.
- Retrieved
- 25 September 2026
Cite as
European Parliament (2026). “DRAFT OPINION on gender inequalities in health, specifically as regards gender-specific conditions”. Text, 11 February 2026. docId SANT-PA-784154. EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/texts/SANT-PA-784154 (retrieved 25 September 2026). Data: EP Open Data API: document record, https://data.europarl.europa.eu/api/v2/documents/SANT-PA-784154 (CC BY 4.0).
BibTeX
@misc{epw-text-sant-pa-784154,
author = {{European Parliament}},
title = {{DRAFT OPINION on gender inequalities in health, specifically as regards gender-specific conditions}},
year = {2026},
date = {2026-02-11},
howpublished = {\url{https://news.eu-parl.st-solutions.dev/texts/SANT-PA-784154}},
url = {https://news.eu-parl.st-solutions.dev/texts/SANT-PA-784154},
urldate = {2026-09-25},
publisher = {EU Parl Watch Research},
note = {Text. docId SANT-PA-784154. Data: EP Open Data API: document record (CC BY 4.0)}
}